SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kyla N. Velaer, Ryan L. Steinberg, Lewis J. Thomas, Michael A. O’Donnell, Kenneth G. Nepple, Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer, Current Urology Reports, 2016, 17, 5

    CrossRef

  2. 2
    Ryan L. Steinberg, Lewis J. Thomas, Kenneth G. Nepple, Intravesical and alternative bladder-preservation therapies in the management of non–muscle-invasive bladder cancer unresponsive to bacillus Calmette-Guérin, Urologic Oncology: Seminars and Original Investigations, 2016,

    CrossRef

  3. 3
    Lijun Mao, Chunhua Yang, Liantao Li, Lanzhou Nai, Li Fan, Junqi Wang, Wang Li, Rumin Wen, Jiacun Chen, Junnian Zheng, Replication-competent adenovirus expressing TRAIL synergistically potentiates the antitumor effect of gemcitabine in bladder cancer cells, Tumor Biology, 2014, 35, 6, 5937

    CrossRef

  4. 4
    L. Neutsch, E.-M. Wirth, S. Spijker, C. Pichl, H. Kählig, F. Gabor, M. Wirth, Synergistic targeting/prodrug strategies for intravesical drug delivery — Lectin-modified PLGA microparticles enhance cytotoxicity of stearoyl gemcitabine by contact-dependent transfer, Journal of Controlled Release, 2013, 169, 1-2, 62

    CrossRef

  5. 5
    Lukas Neutsch, Michael Wambacher, Eva-Maria Wirth, Sylvia Spijker, Hanspeter Kählig, Michael Wirth, Franz Gabor, UPEC biomimickry at the urothelial barrier: Lectin-functionalized PLGA microparticles for improved intravesical chemotherapy, International Journal of Pharmaceutics, 2013, 450, 1-2, 163

    CrossRef

  6. 6
    Rianne JM Lammers, J Alfred Witjes, Developments in intravesical therapy for non-muscle-invasive bladder cancer, Expert Review of Anticancer Therapy, 2010, 10, 12, 1903

    CrossRef

  7. 7
    Giuseppe Di Lorenzo, Sisto Perdonà, Rocco Damiano, Adriana Faiella, Francesco Cantiello, Sandro Pignata, Paolo Ascierto, Ester Simeone, Marco De Sio, Riccardo Autorino, Gemcitabine versus bacille Calmette-Guérin after initial bacille Calmette-Guérin failure in non-muscle-invasive bladder cancer, Cancer, 2010, 116, 8
  8. 8
    Mohamed Ali Elkoushy, Intravesical gemcitabine for treatment of superficial bladder cancer not responding to Bacillus Calmette-Guérin vaccine, African Journal of Urology, 2010, 16, 4, 110

    CrossRef

  9. 9
    Sisto Perdonà, Giuseppe Di Lorenzo, Francesco Cantiello, Rocco Damiano, Marco De Sio, Daniele Masala, Gianni Bruni, Luigi Gallo, Piera Federico, Carmelo Quattrone, Mariano Pizzuti, Riccardo Autorino, Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial, Anti-Cancer Drugs, 2010, 21, 1, 101

    CrossRef

  10. 10
    Andreas Böhle, Herbert Leyh, Christian Frei, Michael Kühn, Reinhold Tschada, Tobias Pottek, Walter Wagner, Helmut H. Knispel, Wolfgang von Pokrzywnitzki, Ferruh Zorlu, Karin Helsberg, Birgit Lübben, Victoria Soldatenkova, Clemens Stoffregen, Hartwig Büttner, Single Postoperative Instillation of Gemcitabine in Patients with Non-muscle-invasive Transitional Cell Carcinoma of the Bladder: A Randomised, Double-blind, Placebo-controlled Phase III Multicentre Study, European Urology, 2009, 56, 3, 495

    CrossRef

  11. 11
    Daniel A Barocas, Peter E Clark, Bladder cancer, Current Opinion in Oncology, 2008, 20, 3, 307

    CrossRef

  12. 12
    Jong Wook Kim, Dae Yeon Cho, Jeong Kyun Yeo, Hong Seok Park, Duck Ki Yoon, Initial Experiences of Intravesical Gemcitabine Instillation Followed by Bacillus Calmette-Guerin (BCG) Therapy for Treating Intermediate or High Risk Patients with Superficial Bladder Cancer, Korean Journal of Urology, 2008, 49, 4, 313

    CrossRef

  13. 13
    Peter E Clark, Bladder cancer, Current Opinion in Oncology, 2007, 19, 3, 241

    CrossRef

  14. 14
    Paola Gazzaniga, Ida Silvestri, Angela Gradilone, Susanna Scarpa, Stefania Morrone, Orietta Gandini, Walter Gianni, Luigi Frati, Anna Maria Aglian??, Gemcitabine-induced apoptosis in 5637 cell line: an in-vitro model for high-risk superficial bladder cancer, Anti-Cancer Drugs, 2007, 18, 2, 179

    CrossRef

  15. 15
    Christian Bolenz, Andreas Becker, Lutz Trojan, Axel Schaaf, Yanwei Cao, Christel Weiss, Peter Alken, Maurice Stephan Michel, Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides, Urologic Oncology: Seminars and Original Investigations, 2007, 25, 6, 476

    CrossRef

  16. 16
    Eric S Gwynn, Peter E Clark, Bladder cancer, Current Opinion in Oncology, 2006, 18, 3, 277

    CrossRef

  17. 17
    Christian Bolenz, Yanwei Cao, Mario Fernández Arancibia, Lutz Trojan, Peter Alken, Maurice Stephan Michel, Intravesical mitomycin C for superficial transitional cell carcinoma, Expert Review of Anticancer Therapy, 2006, 6, 8, 1273

    CrossRef